Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Celcuity Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Research and development
3.06
4.98
6.33
6.27
7.68
25.8
35.3
60.6
104
145
General and administrative
0.26
0.97
1.61
1.54
1.87
2.6
4.1
5.64
9.06
27.2
Operating expenses
3.33
5.95
7.93
7.81
9.56
28.4
39.4
66.2
113
172
Operating income
-3.33
-5.95
-7.93
-7.81
-9.56
-28.4
-39.4
-66.2
-113
-172
Interest expense
0
0.45
0
0
0
1.26
2.11
5.33
10.3
17.1
Interest income
0.02
0.15
0.45
0.45
0.08
0.01
1.13
7.78
11.8
12.3
Other non-operating income
0.02
-0.3
0.45
0.45
0.08
-1.25
-0.98
2.45
1.49
-4.85
Pre-tax income
-3.31
-6.25
-7.48
-7.36
-9.47
-29.6
-40.4
-63.8
-112
-177
Income tax
0
0
0
0
0
Net income
-3.31
-6.25
-7.48
-7.36
-9.47
-29.6
-40.4
-63.8
-112
-177
EBITDA
-3.26
-5.85
-7.71
-7.47
-9.17
-28.1
-39.2
-66.1
-113
-172
EPS, basic
-0.52
-0.84
-0.74
-0.72
-0.92
-2.21
-2.64
-2.69
-2.83
-3.79
EPS, diluted
-0.52
-0.84
-0.74
-0.72
-0.92
-2.21
-2.64
-2.69
-2.83
-3.79
Shares, basic (weighted)
6.31
7.46
10.1
10.2
10.3
13.4
15.4
23.7
39.4
46.8
Shares, diluted (weighted)
6.31
7.46
10.1
10.2
10.3
13.4
15.4
23.7
39.4
46.8
Balance sheet
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
5.86
2.69
15.9
18.7
11.6
84.3
24.6
30.7
22.5
166
Short-term investments
0
21.6
8.95
0
144
150
213
276
Other current assets
0
0.21
0.27
0.27
0.32
0.72
6.6
10
2.7
5.27
Total current assets
5.91
24.5
25.2
19.3
12.2
85.4
175
191
245
466
Property, plant and equipment
0.14
0.28
0.81
0.83
0.56
0.31
0.26
0.23
0.34
0.5
Lease right-of-use assets
0
0.2
0.23
0.24
0.25
0.4
0.22
0.05
Long-term investments
0
7.21
0
Other non-current assets
0.35
Total assets
6.06
32
26
20.3
13
85.9
176
191
245
467
Accounts payable
0.33
0.07
0.12
0.14
0.22
1.51
2.63
5.08
9.37
6.41
Accrued liabilities
0.11
0.51
0.54
0.58
0.77
0.8
4.06
8.93
22.2
Total current liabilities
0.45
0.58
0.66
0.91
1.19
2.51
6.88
14.2
31.7
44.2
Long-term debt
0
14.6
35
37
97.7
127
Lease liabilities
0
0.06
0.06
0.06
0.06
0.23
0.05
Total liabilities
0.45
0.58
0.68
0.98
1.25
17.2
41.9
51.5
130
366
Total debt
16
35.8
37.6
105
138
Paid-in capital
0.59
33.4
34.8
36.1
38
125
230
300
387
549
Retained earnings
-8.33
-2.01
-9.49
-16.8
-26.3
-55.9
-96.3
-160
-272
-449
Shareholders' equity
5.61
31.4
25.3
19.3
11.7
68.7
134
140
116
101
Total equity
5.61
31.4
25.3
19.3
11.7
68.7
134
140
116
101
Total liabilities and equity
6.06
32
26
20.3
13
85.9
176
191
245
467
Shares outstanding
0
10.1
10.2
10.3
10.3
14.9
21.7
25.5
37.1
48.2
Cash flow statement
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-3.31
-6.25
-7.48
-7.36
-9.47
-29.6
-40.4
-63.8
-112
-177
Depreciation and amortization
0.07
0.1
0.22
0.34
0.39
0.3
0.21
0.14
0.13
0.17
Stock-based compensation
0.19
0.87
1.17
1.04
1.76
2.61
4.64
4.9
6.99
21.4
Change in payables
0.07
-0.26
0.03
0.05
0.05
1.31
1.08
2.43
4.32
-3.04
Cash from operations
-2.89
-4.95
-6.08
-6
-7.15
-20.3
-36
-53.8
-83.5
-153
Capital expenditures
-0.04
-0.24
-0.63
0.38
-0.09
-0.08
-0.16
-0.1
-0.25
-0.25
Purchases of investments
0
-28.7
-3.24
0
-144
-315
-705
-396
Cash from investing
-0.04
-29
19.1
8.53
-0.09
-0.08
-144
-5.01
-63.1
-64.1
Stock issued
0
0.17
0
0.06
0.15
0.39
0.77
3.49
Cash from financing
3.72
30.7
0.24
0.26
0.14
93
120
64.9
138
361
Net change in cash
0.79
-3.22
13.3
2.79
-7.1
72.6
-59.7
6.09
-8.15
143
Free cash flow
-2.93
-5.19
-6.71
-5.62
-7.24
-20.4
-36.2
-53.9
-83.7
-154
Interest paid
0
0.69
1.26
3.27
7.59
10.3
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $79.52 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Return on assets (ROA)
-27.3%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
-13.0%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-9.1%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
53.8%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
90.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
38.5%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
104.8%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
18.5%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
44.7%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
35.4%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
8.93x
Current assets / current liabilities.
Quick ratio
8.68x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
8.68x
(Cash + short-term investments) / current liabilities.
Debt / assets
0.0%
Total debt / total assets.
Liabilities / assets
101.5%
Total liabilities / total assets.
Net debt
-$754.0M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
FCF per share
-$3.51
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$3.50
Cash from operations / diluted weighted shares.
Book value per share
-$0.26
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
FCF yield
-4.9%
Free cash flow / market cap.
Earnings yield
-5.8%
Net income / market cap (the inverse of P/E).
Was Celcuity Inc. profitable in fiscal 2025?
No. It reported a net loss of $177.0M.
How much free cash flow did Celcuity Inc. generate in fiscal 2025?
Cash from operations of $153.3M minus capital expenditures of $249.0K left free cash flow of -$153.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.